GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Days Sales Outstanding

Fulgent Genetics (MEX:FLGT) Days Sales Outstanding : 69.92 (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Days Sales Outstanding?

Fulgent Genetics's average Accounts Receivable for the three months ended in Sep. 2024 was MXN1,082 Mil. Fulgent Genetics's Revenue for the three months ended in Sep. 2024 was MXN1,413 Mil. Hence, Fulgent Genetics's Days Sales Outstanding for the three months ended in Sep. 2024 was 69.92.

The historical rank and industry rank for Fulgent Genetics's Days Sales Outstanding or its related term are showing as below:

MEX:FLGT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.74   Med: 67.85   Max: 110.53
Current: 70

During the past 10 years, Fulgent Genetics's highest Days Sales Outstanding was 110.53. The lowest was 47.74. And the median was 67.85.

MEX:FLGT's Days Sales Outstanding is ranked worse than
55.4% of 213 companies
in the Medical Diagnostics & Research industry
Industry Median: 65.69 vs MEX:FLGT: 70.00

Fulgent Genetics's Days Sales Outstanding increased from Sep. 2023 (45.01) to Sep. 2024 (69.92).


Fulgent Genetics Days Sales Outstanding Historical Data

The historical data trend for Fulgent Genetics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Days Sales Outstanding Chart

Fulgent Genetics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.52 82.26 58.32 58.65 70.50

Fulgent Genetics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.01 65.81 73.84 66.63 69.92

Competitive Comparison of Fulgent Genetics's Days Sales Outstanding

For the Diagnostics & Research subindustry, Fulgent Genetics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fulgent Genetics's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Fulgent Genetics's Days Sales Outstanding falls into.



Fulgent Genetics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Fulgent Genetics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (1028.395 + 867.927) / 2 ) / 4909.173*365
=948.161 / 4909.173*365
=70.50

Fulgent Genetics's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding (Q: Sep. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Sep. 2024 )) / count ) / Revenue (A: Sep. 2024 )*Days in Period
=( (1036.423 + 1128.55) / 2 ) / 1412.641*365 / 4
=1082.4865 / 1412.641*365 / 4
=69.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fulgent Genetics  (MEX:FLGT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Fulgent Genetics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Fulgent Genetics Business Description

Traded in Other Exchanges
Address
4399 Santa Anita Avenue, El Monte, CA, USA, 91731
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.